![]() |
市場調査レポート
商品コード
1661255
点滴液の市場規模、シェア、動向、予測:タイプ別、栄養素別、地域別、2025年~2033年Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2025-2033 |
||||||
カスタマイズ可能
|
点滴液の市場規模、シェア、動向、予測:タイプ別、栄養素別、地域別、2025年~2033年 |
出版日: 2025年02月10日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2~3営業日
|
点滴液の市場の世界市場規模は、2024年に156億米ドルとなった。今後、IMARC Groupは、2033年には233億米ドルに達し、2025~2033年のCAGRは4.53%になると予測しています。現在市場を独占しているのは北米で、2024年の市場シェアは40.7%を超えます。北米地域の成長の原動力は、高度なヘルスケアインフラ、慢性疾患の増加、高齢者人口の増加です。
静脈注射液とは、患者の血流に直接輸液するための無菌液体を指します。等張液、高張液、低張液があり、さまざまな医療ニーズに対応しています。水、電解質、糖、ビタミン、薬剤など、さまざまな成分を用いて製造されます。輸液は、水分補給療法、栄養補給、薬物投与、輸血、化学療法、疼痛管理、電解質不均衡の是正、解毒治療などに広く使用されています。管理された投与、消化器系への影響の軽減、オーダーメイドの栄養供給、血流への直接アクセス、回復支援の強化など、いくつかの利点があります。
病院、診療所、専門医療センターなどのヘルスケア施設の急速な拡大により、静脈内治療の機会が増えていることが、市場の成長を後押ししています。さらに、ヘルスケア施設全体で高品質の点滴ソリューションを利用できるようにするため、政府や規制機関が支援政策を打ち出していることも、市場成長にプラスの影響を与えています。さらに、緊急事態や外科手術における点滴ソリューションの需要の高まりが、市場の成長に寄与しています。これとは別に、患者が自宅で治療を受ける在宅ヘルスケアへのシフトが進んでいることも、特殊な点滴ソリューションの需要を促進しています。このほか、パンデミックのような世界の健康上の緊急時に多数の患者を迅速に治療するための製品用途が増加していることも、市場の成長を促進しています。
疾病有病率の増加
糖尿病、心血管疾患、がん、急性疾患など、点滴治療を必要とする慢性疾患の有病率の増加は、市場成長を促進する顕著な要因です。さらに、慢性疾患の増加につながるライフスタイルの変化、環境要因、遺伝的素因などの新たな世界の動向が、もう一つの成長促進要因として作用しています。さらに、いくつかの慢性疾患や急性疾患では、輸液、栄養剤、薬剤を血流に直接投与する必要があります。これに伴い、輸液ソリューションは必要不可欠な栄養素や薬剤の正確な送達を容易にし、患者の迅速な回復を保証します。さらに、特に危機的な状況において、より迅速で統制のとれた治療が可能になります。
老年人口の増加
老年人口の増加は、輸液市場の成長に大きく寄与しています。高齢化社会は様々な健康問題や慢性疾患にかかりやすく、点滴療法を含む複雑な医療介入を必要とすることが多いため、市場の成長を後押ししています。さらに、免疫力の低下、臓器機能の低下、その他の加齢に伴う生理的変化によって、老年人口が感染症や疾病にかかりやすくなっていることも、市場の成長を促進しています。これに伴い、点滴ソリューションは必要不可欠な水分補給、栄養補給、薬物投与に不可欠であり、治療が的を絞った効率的なものとなることを保証します。さらに、ナトリウム、カリウム、カルシウム、マグネシウムなどの電解質の不均衡を回復するために静脈注射液が広く利用されていることも、成長を促進する要因となっています。
急速な技術進歩
医療と輸液製造の技術的進歩が市場成長に寄与しています。これに伴い、新技術はより専門的な溶液の調合を可能にし、特定の患者のニーズに対応し、静脈内治療の効率性と安全性を高めています。さらに、医療従事者がより高い精度と制御性で治療を実施できるようにする輸液ポンプや送達システムの最近の技術革新は、市場成長にプラスの影響を与えています。さらに、合併症のリスクを低減し、患者の転帰を改善するための点滴療法のモニタリングと管理における技術的ブレークスルーが、もう一つの成長促進要因として作用しています。さらに、生体適合性、個別化された治療計画、人工知能(AI)などの技術を統合して治療を強化することに焦点を当てた広範な研究開発(R&D)の取り組みが、市場の成長を支えています。
The global intravenous solutions market size was valued at USD 15.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 23.3 Billion by 2033, exhibiting a CAGR of 4.53% from 2025-2033. North America currently dominates the market, holding a market share of over 40.7% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, rising chronic disease prevalence, and increasing elderly population.
Intravenous (IV) solutions refer to sterile liquids used to administer fluids directly into a patient's bloodstream. It includes isotonic, hypertonic, and hypotonic solutions, catering to different medical needs. They are produced using various ingredients, such as water, electrolytes, sugars, vitamins, and medications. IV solutions are widely used in hydration therapy, nutritional support, medication delivery, blood transfusion, chemotherapy, pain management, correcting electrolyte imbalances, and detoxification treatments. They offer several benefits, such as controlled administration, reduced digestive system impact, tailored nutrient delivery, direct bloodstream access, and enhanced recovery support.
The rapid expansion of healthcare facilities, such as hospitals, clinics, and specialized care centers, which are generating more opportunities for IV treatments, is propelling the market growth. Additionally, the imposition of supportive policies by governments and regulatory bodies to ensure the availability of high-quality intravenous solutions across healthcare facilities is positively influencing the market growth. Furthermore, the growing demand for IV solutions in emergency scenarios and surgical procedures is contributing to the market growth. Apart from this, the increasing shift towards home healthcare, where patients receive treatment in their own homes, is facilitating the demand for specialized IV solutions. Besides this, the rising product application in treating a large number of patients quickly during global health emergencies, such as pandemics, is catalyzing the market growth.
The increasing prevalence of disease
The heightened prevalence of chronic diseases, such as diabetes, cardiovascular ailments, cancer, and acute conditions, which necessitate IV treatments, is a prominent factor propelling the market growth. Furthermore, emerging global trends, such as lifestyle changes, environmental factors, and genetic predispositions, which lead to an increase in chronic conditions, are acting as another growth-inducing factor. Additionally, several chronic and acute illnesses require direct administration of fluids, nutrients, or medications into the bloodstream. In line with this, IV solutions facilitate precise delivery of essential nutrients and medication and ensure quick patient recovery. In addition, they also enable faster, more controlled care, particularly in critical situations.
The rising geriatric population
The rising geriatric population is contributing significantly to the growth of the IV solutions market. The high susceptibility of the aging population to various health issues and chronic conditions, which often require complex medical interventions, including IV therapy, is propelling the market growth. Furthermore, the presence of a weaker immune system, reduced organ functionality, and other age-related physiological changes that make geriatric individuals more prone to infections and diseases are facilitating the market growth. In line with this, IV solutions are vital in providing essential hydration, nutrients, and medications, ensuring that the treatments are targeted and efficient. Moreover, the widespread utilization of IV solutions to restore imbalance in electrolytes, such as sodium, potassium, calcium, and magnesium, is acting as another growth-inducing factor.
The rapid technological advancements
Technological advancements in medical care and the production of IV solutions are contributing to the market growth. In line with this, new technologies are enabling the formulation of more specialized solutions, catering to specific patient needs, and enhancing the efficiency and safety of IV therapies. Furthermore, the recent innovations in infusion pumps and delivery systems, which allow healthcare providers to administer treatments with greater precision and control, are positively influencing the market growth. Additionally, technological breakthroughs in monitoring and managing IV therapies to lower the risk of complications and improve patient outcomes are acting as another growth-inducing factor. Moreover, extensive research and development (R&D) efforts focusing on biocompatibility, personalized treatment plans, and integrating technology, such as artificial intelligence (AI), to augment care are supporting the market growth.
Total parenteral nutrition dominates the market
Total parenteral nutrition (TPN) is dominating the market as it is used to fulfill all the nutritional requirements of patients who cannot eat or absorb enough food through regular digestive means. Additionally, it finds extensive applications across various medical fields, including oncology, gastroenterology, and intensive care units (ICUs). Furthermore, the rising number of chronic conditions, such as cancer and gastrointestinal diseases, that necessitate the use of TPN for nutritional support is propelling the market growth. Apart from this, increasing utilization of TPN to meet the nutritional needs of patients undergoing major surgical procedures is catalyzing the market growth. Moreover, the recent improvements in TPN formulation and administration technology, ensuring safer and more personalized nutrition support, are strengthening the market growth.
Carbohydrates serve as a primary energy source for the human body. They are essential in providing immediate energy, particularly for patients unable to consume food orally. In addition, they are used by all cells in the body, which makes them suitable for a diverse range of patients, irrespective of their specific conditions. Furthermore, carbohydrates can be easily administered through IV solutions, allowing for controlled delivery.
Minerals, such as magnesium, calcium, potassium, and sodium, play critical roles in maintaining various bodily functions, including muscle contraction, nerve transmission, and maintaining fluid balance. Furthermore, IV solutions with specific mineral compositions are essential in correcting electrolyte imbalance, restoring normal cellular function, and stabilizing the patient. Apart from this, minerals are utilized in various medical scenarios, from emergency care to post-operative recovery and chronic disease management.
North America exhibits a clear dominance, accounting for the largest intravenous solutions market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America hosts one of the world's most advanced healthcare systems comprising state-of-the-art medical facilities equipped with cutting-edge technology that is fostering a conducive environment for the utilization of IV solutions. Additionally, the region's healthcare spending is among the highest globally, enabling greater access to quality medical care, including treatments requiring intravenous solutions. Furthermore, the implementation of a comprehensive regulatory framework by the regional governments to ensure that IV solutions meet strict quality and safety standards is boosting the market growth. Apart from this, the high prevalence of chronic conditions like diabetes, heart disease, and cancer, which necessitates regular medical interventions, is acting as another growth-inducing factor. Besides this, North America has a strong network of universities, research institutions, and pharmaceutical companies that are actively investing in developing new intravenous solutions and improving existing ones.
The major players are focusing on creating advanced intravenous products, such as the formulation of new solutions with improved efficiency, the integration of innovative technologies like smart infusion pumps, and the development of personalized therapies. In addition, they are expanding their reach into these regions by setting up new manufacturing facilities, partnering with local distributors, and adapting products to meet specific regional needs. Furthermore, leading companies are engaging in mergers and acquisitions to diversify their product portfolios, leverage synergies, and expand their geographical presence. Moreover, they are placing strong emphasis on quality control and regulatory compliance to ensure that their products meet all relevant safety and efficacy standards. Besides this, top companies in the IV solutions market are focusing on environmentally responsible manufacturing processes and materials by reducing waste and energy consumption and using sustainable resources.